Application 021878
- Type
- BLA
- Sponsor
- NOVO NORDISK
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVEMIR | INSULIN DETEMIR | INJECTABLE; INJECTION | 100 UNITS/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levemir | INSULIN DETEMIR | A-S Medication Solutions | 82192527-99aa-4b53-8ce9-9173668d309c | 2024-10-09 | Warnings, Adverse reactions | Levemir INSULIN DETEMIR |
| Levemir | INSULIN DETEMIR | Novo Nordisk | d38d65c1-25bf-401d-9c7e-a2c3222da8af | 2022-12-08 | Warnings, Adverse reactions | Levemir INSULIN DETEMIR |